Evidence map›Paper›PMID 35862703›Full record

ArticleInfection and immunity2022

Mycoplasma pneumoniae Compared to Streptococcus pneumoniae Avoids Induction of Proinflammatory Epithelial Cell Responses despite Robustly Inducing TLR2 Signaling.

R C A de Groot, H Zhu, T Hoogenboezem, A C J M de Bruijn, E Eenjes, A E J 't Jong, A I Belo, S C Estevão, J J Bajramovic, R J Rottier and 3 more

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Modeling chronic infection withInfection and immunity · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Identification ofFrontiers in microbiology · 2024
    Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

R C A de GrootLaboratory of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Erasmus MCgrid.5645.2 University Medical Center Rotterdam-Sophia Children's Hospital, Rotterdam, The Netherlands.ORCID 0000-0002-5071-2781
H ZhuLaboratory of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Erasmus MCgrid.5645.2 University Medical Center Rotterdam-Sophia Children's Hospital, Rotterdam, The Netherlands.
T HoogenboezemLaboratory of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Erasmus MCgrid.5645.2 University Medical Center Rotterdam-Sophia Children's Hospital, Rotterdam, The Netherlands.
A C J M de BruijnLaboratory of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Erasmus MCgrid.5645.2 University Medical Center Rotterdam-Sophia Children's Hospital, Rotterdam, The Netherlands.
E EenjesDepartment of Pediatric Surgery and Department of Cell Biology, Erasmus MCgrid.5645.2 University Medical Center Rotterdam-Sophia Children's Hospital, Rotterdam, The Netherlands.
A E J 't JongAlternatives Unit, Biomedical Primate Research Centregrid.11184.3d, Rijswijk, The Netherlands.
A I BeloLaboratory of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Erasmus MCgrid.5645.2 University Medical Center Rotterdam-Sophia Children's Hospital, Rotterdam, The Netherlands.
S C EstevãoLaboratory of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Erasmus MCgrid.5645.2 University Medical Center Rotterdam-Sophia Children's Hospital, Rotterdam, The Netherlands.
J J BajramovicAlternatives Unit, Biomedical Primate Research Centregrid.11184.3d, Rijswijk, The Netherlands.
R J RottierDepartment of Pediatric Surgery and Department of Cell Biology, Erasmus MCgrid.5645.2 University Medical Center Rotterdam-Sophia Children's Hospital, Rotterdam, The Netherlands.
M KoolDepartment of Pulmonary Medicine, Erasmus MCgrid.5645.2 University Medical Center Rotterdam, Rotterdam, The Netherlands.
A M C van RossumDepartment of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Erasmus MCgrid.5645.2 University Medical Center Rotterdam-Sophia Children's Hospital, Rotterdam, The Netherlands.
W W J UngerLaboratory of Pediatrics, Division of Pediatric Infectious Diseases and Immunology, Erasmus MCgrid.5645.2 University Medical Center Rotterdam-Sophia Children's Hospital, Rotterdam, The Netherlands.
Erasmus MC · NLBiomedical Primate Research Centre · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mycoplasma pneumoniae and Streptococcus pneumoniae are the most common bacterial causes of pneumonia in children. The clinical characteristics of pneumonia differ significantly between the two bacteria. We aimed to elucidate the differences in pathogenesis between M. pneumoniae and S. pneumoniae by characterizing the respiratory epithelial cell immune response to both pathogens. Using primary human bronchial epithelial cells in air-liquid interface cultures, we observed lower production of the proinflammatory cytokines interleukin-6 (IL-6) and IL-8 in response to M. pneumoniae than to S. pneumoniae. In contrast to the differences in proinflammatory cytokine production, Toll-like receptor 2 (TLR2)-mediated signaling in response to M. pneumoniae was stronger than to S. pneumoniae. This difference largely depended on TLR1 and not TLR6. We found that M. pneumoniae, but not S. pneumoniae, also induced signaling of TLR10, a coreceptor of TLR2 that has inhibitory properties. M. pneumoniae-induced TLR10 signaling on airway epithelial cells was partially responsible for low IL-8 production, as blocking TLR10 by specific antibodies increased cytokine production. M. pneumoniae maintained Th2-associated cytokine production by epithelial cells, which concurs with the known association of M. pneumoniae infection with asthma. M. pneumoniae left IL-33 levels unchanged, whereas S. pneumoniae downregulated IL-33 production both under homeostatic and Th2-promoting conditions. By directly comparing M. pneumoniae and S. pneumoniae, we demonstrate that M. pneumoniae avoids induction of proinflammatory cytokine response despite its ability to induce robust TLR2 signaling. Our new findings suggest that this apparent paradox may be partially explained by M. pneumoniae-induced signaling of TLR2/TLR10.

Indexed as

Mycoplasma pneumoniaeStreptococcus pneumoniaeChildCytokinesEpithelial CellsHumansInterleukin-33Interleukin-8Toll-Like Receptor 2CytokinesInterleukin-33Interleukin-8TLR2 protein, humanToll-Like Receptor 2host responseIL-33IL-8Mycoplasma pneumoniaepneumoniaprimary bronchial epithelial cellsrespiratory pathogensStreptococcus pneumoniaeTLR10TLR2

Identifiers

PMID35862703
PMCPMC9387261
OpenAlexW4285012353

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.